Key Segmentation
By Product and Service
-
RNA-Seq Platforms and Consumables
-
Sample Preparation Products
-
RNA-Seq Services
-
Data Analysis and Storage
By Technology
-
Sequencing by Synthesis
-
Ion Semiconductor Sequencing
-
Single-Molecule Real-Time Sequencing
-
Nanopore Sequencing
By Application
-
Drug Discovery and Development
-
Clinical Diagnostics
-
Biomarker and Translational Research
-
Basic and Academic Research
-
Others
Regional Coverage:
North America
-
United States
-
Canada
Europe
-
Germany
-
United Kingdom
-
France
-
Italy
-
Spain
-
Russia
-
Poland
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
The market was valued at USD 4.32 Billion in 2025 and is projected to reach USD 22.46 Billion by 2035.
The market is expected to register a CAGR of 17.92% from 2026 to 2035.
North America led the market with a 44.60% share in 2025.
Asia Pacific is expected to grow the fastest, at a CAGR of 19.06% from 2026 to 2035.
RNA-seq platforms and consumables led the product and service segment with a 53.40% share in 2025, and drug discovery and development led the application segment.